Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Gcl Technology Holdings Ord Shs GCPEF

GCL Technology Holdings Ltd, formerly GCL-Poly Energy Holdings Ltd, is an investment holding company mainly engaged in the manufacture and sale of solar materials. The Company operates its business through three segments. The Solar Material Business segment is mainly engaged in the manufacture and sale of polysilicon and wafer products to companies operating in the solar industry. The New Energy Business segment is engaged in the development, construction, operation and management of solar farms. The Solar Farm Business segment is engaged in the operation and management of solar farms.


OTCPK:GCPEF - Post by User

Post by LannyMcdonaldon Jan 04, 2017 4:08am
138 Views
Post# 25664762

none

nonePatient tests per month were ~22,000 this October, are expected to be ~26,000 for November, and are expected to increase to between 60,000 - 70,000 patients per month in 2017. As impressive as those increases in patient tests are, it is only just the beginning. How big will this get? The answer is 'we just don't know', but there are numerous indicators ADK.V is going on a massive run..................................................... Government involvement with DIAGNOS is the big prize for shareholders; when key news is announced, we anticipate it will act as a major catalyst that will supplant all current projections and cause a dramatic upside revaluation in share price, well above what is being discussed here today.
<< Previous
Bullboard Posts